Pharmacology and the Nursing Process: Chapter 32: Antidiabetic Drugs Flashcards

Cards
 Quiz

Matching

UPDATED
Bingo

Print Print
Set Details Share
created 8 years ago by mens05
1,835 views
book cover
Antidiabetic Drugs
updated 7 years ago by mens05
Subjects:
nursing
show moreless
Page to share:
Embed this setcancel
COPY
code changes based on your size selection
Size:
X
Show:

1

Diabetes Mellitus

A complex disorder of carbohydrate, fat, and protein metabolism resulting from the lack of insulin secretion by the beta cells of the pancreas or from defects of the insulin receptors; it is commonly referred to simply as diabetes. There are two major types of diabetes: type 1 and type 2.

2

Diabetic Ketoacidosis (DKA)

A severe metabolic complication of uncontrolled diabetes that, if untreated, leads to diabetic coma and death.

3

Gestational Diabetes

Diabetes that develops during pregnancy. It may resolve after pregnancy but may also be a precursor of type 2 diabetes in later life.

4

Glucagon

A hormone produced by the alpha cells in the islets of Langerhans that stimulates the conversion of glycogen to glucose in the liver.

5

Glucose

One of the simple sugars that serves as a major source of energy. It is found in foods (e.g., refined sweets) and also is the final breakdown product of complex carbohydrate metabolism in the body; it is commonly referred to as dextrose.

6

Glycogen

A polysaccharide that is the major carbohydrate stored in animal cells.

7

Glycogenolysis

The breakdown of glycogen to glucose.

8

Hemoglobin A1C (A1C)

Hemoglobin molecules bound to glucose molecules; blood levels of hemoglobin A1C are used as a diagnostic measure of average daily blood glucose levels in the monitoring and diagnosing of diabetes; it is also called glycosylated hemoglobin and most commonly referred to as A1C.

9

Hyperglycemia

A fasting blood glucose level of 126 mg/dL or higher or a nonfasting blood glucose level of 200 mg/dL or higher.

10

Hyperosmolar Hyperglycemic Syndrome (HHS)

A metabolic complication of uncontrolled type 2 diabetes, similar in severity to diabetic ketoacidosis but without ketosis and acidosis.

11

Hypoglycemia

A blood glucose level of less than 70 mg/dL, or above 50 mg/dL with signs and symptoms of hypoglycemia.

12

Insulin

A naturally occurring hormone secreted by the beta cells of the islets of Langerhans in the pancreas in response to increased levels of glucose in the blood.

13

Ketones

Organic chemical compounds produced through the oxidation of secondary alcohols (e.g., fat molecules), including dietary carbohydrates.

14

Polydipsia

Chronic excessive intake of water; it is a common symptom of uncontrolled diabetes.

15

Polyphagia

Excessive eating; it is a common symptom of uncontrolled diabetes.

16

Polyuria

Increased frequency or volume of urinary output; it is a common symptom of diabetes.

17

Type 1 Diabetes Mellitus

Diabetes mellitus that is a genetically determined autoimmune disorder characterized by a complete or nearly complete lack of insulin production; it most commonly arises in children or adolescents.

18

Type 2 Diabetes Mellitus

Diabetes mellitus that most commonly presents in adults and is becoming more common in children and adolescents due to inactivity and weight gain. The disease may be controlled by lifestyle modifications, oral drug therapy, and/or insulin, but patients are not necessarily dependent on insulin therapy.

19

Pancreas

It is both an exocrine gland (secreting digestive enzymes through the pancreatic duct) and an endocrine gland (secreting hormones directly into the bloodstream and not through a duct)

20

Insulin

Is required in patients with type 1 diabetes

21

Exogenous Insulin

Functions as a substitute for the endogenous hormone. It serves to replace the insulin that is either not made or is made defectively in a diabetic patient.

22

Rapid Acting Insulin

  • Lispro (Humalog)
  • Aspart (NovoLog)
  • Glulisine (Apidra)

23

Lispro (Humalog), Aspart (NovoLog), Glulisine (Apidra)

These have the most rapid onset of action as well as a shorter duration of action than other insulin categories.

  • Route - Subcutaneous
  • Onset of Action - 15 min
  • Peak Plasma Concentration - 1-2 hr
  • Elimination Half-life - 80 min
  • Duration of Action - 3-5 hr

24

Short Acting Insulin

  • Regular (Humulin R)

25

Regular (Humulin R)

The only Insulin classified as a short-acting insulin.

  • Route - Subcutaneous
  • Onset of Action - 30-60 min
  • Peak Plasma Concentration - 2.5 hr
  • Elimination Half-life - Unknown
  • Duration of Action - 6-10 hr

26

Intermediate Acting Insulin

  • Isophane Suspension (NPH)

27

Isophane Suspension (NPH Insulin)

The only available intermediate-acting insulin product.

  • Route - Subcutaneous
  • Onset of Action - 1-2 hr
  • Peak Plasma Concentration - 4-8 hr
  • Elimination Half-life - Unknown
  • Duration of Action - 10-18 hr

28

Long Acting Insulin

  • Glargine (Lantus)
  • Detemir (Levemir)

29

Glargine (Lantus), Detemir (Levemir)

Long-acting insulin products.

  • Route - Subcutaneous
  • Onset of Action - 1-2 hr
  • Peak Plasma Concentration - None
  • Elimination Half-life - Unknown
  • Duration of Action - 24 hr

30

Fixed-Combination Insulin

  • Humulin 70/30
  • Humulin 50/50
  • Novolin 70/30
  • Humalog Mix 75/25
  • Humalog 50/50
  • NovoLog 70/30

31

Humulin 70/30, Humulin 50/50, Novolin 70/30, Humalog Mix 75/25, Humalog 50/50, NovoLog 70/30

These products contains two different insulins; one intermediate-acting type and either one rapid-acting type or one short-acting type.

32

Sliding Scale

In this method, subcutaneous doses of rapid-acting or short-acting insulin are adjusted according to blood glucose test results.

33

Basal-Bolus Therapy

Is the attempt to mimic a healthy pancreas by delivering insulin constantly and then as needed.

34

Biguanide

Metformin is currently the only drug classified as this. It is considered a first-line drug and is the most commonly used oral drug for the treatment of type 2 diabetes.

35

Sulfonylureas

These are the oldest group of oral antidiabetic drugs. Those currently used are second-generation drugs and have a better potency and adverse effect profile than first-generation drugs.

36

Glinides

Repaglinide (Prandin) and nateglinide (Starlix) are currently the only two drugs in this class. They are structurally different but have a similar mechanism of action in that they also increase insulin secretion from the pancreas.

37

Thiazolidinediones (Glitazones)

This class of drugs acts by regulating genes involved in glucose and lipid metabolism. These drugs are also known to directly stimulate peripheral glucose uptake and storage, as well as to inhibit glucose and triglyceride production in the liver.

38

Alpha-Glucosidase Inhibitors

Less commonly used oral drugs are acarbose (Precose) and miglitol (Glyset). As the name implies, these drugs work by reversibly inhibiting the enzyme that is found in the small intestine.

39

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors

Work by delaying the breakdown of incretin hormones by inhibiting the enzyme DPP-IV. Incretin hormones are released throughout the day and are increased after a meal.

40

Acarbose (Precose)

One of the two currently available alpha-glucosidase inhibitors.

  • Route - PO
  • Onset of Action - 1-1.5 hr
  • Peak Plasma Concentration - 2 hr
  • Elimination Half-life - 2-3 hr
  • Duration of Action - Unknown

41

Glipizide (Glucotrol)

A second-generation sulfonylurea drug. In contrast to another second-generation sulfonylurea, it has a very rapid onset and short duration of action, with no active metabolites.

  • Route - PO
  • Onset of Action - 1 hr
  • Peak Plasma Concentration - 1-3 hr
  • Elimination Half-life - 2-5 hr
  • Duration of Action - 6-8 hr

42

Metformin (Glucophage)

Currently the only biguanide oral antidiabetic drug. It works by inhibiting hepatic glucose production and increasing the sensitivity of peripheral tissue to insulin.

  • Route - PO
  • Onset of Action - Less than 1 hr
  • Peak Plasma Concentration - 1-3 hr
  • Elimination Half-life - 1.5-5 hr
  • Duration of Action - 24 hr

43

Pioglitazone (Actos)

Classified as a glitazone or derivative, used alone or with a sulfonylurea, metformin, or insulin. It works by decreasing insulin resistance.

  • Route - PO
  • Onset of Action - Delayed
  • Peak Plasma Concentration - 2 hr
  • Elimination Half-life - 3-7 hr
  • Duration of Action - Unknown

44

Repaglinide (Prandin)

One of two antidiabetic drugs classified as glinides, the other being nateglinide (Starlix). These drugs have a mechanism of action similar to that of the sulfonylureas in that they also stimulate the release of insulin from pancreatic beta cells.

  • Route - PO
  • Onset of Action - 15-60 min
  • Peak Plasma Concentration - 1 hr
  • Elimination Half-life - 2-3 hr
  • Duration of Action - 4-6 h

45

Sitagliptin (Januvia)

Was the first DPP-IV inhibitor approved. It is an oral drug that selectively inhibits the action of DPP-IV, thus increasing concentrations of the naturally occurring incretins GLP-1 and GIP.

  • Route - PO
  • Onset of Action - 15-30 min
  • Peak Plasma Concentration - 1 hr
  • Elimination Half-life - 12 hr
  • Duration of Action - Unknown

46

Amylin Agonists

Is a natural hormone secreted by the beta cells of the pancreas along with insulin in response to food. It functions to decrease postprandial plasma glucose levels, which it accomplishes in the following three ways: (1) It slows gastric emptying; (2) suppresses glucagon secretion and hepatic glucose production; and (3) increases satiety (sense of having eaten enough).

47

Incretin Mimetics

Are hormones released by the gastrointestinal tract in response to food, they do the following: stimulate insulin secretion; reduce postprandial glucagon production; slow gastric emptying; and increase satiety.

48

Liraglutide (Victoza)

Is an incretin mimetic drug, it enhances glucose-dependent insulin secretion, suppress elevated glucagon secretion, and slow gastric emptying.

  • Route - Subcutaneous
  • Onset of Action - 3 min
  • Peak Plasma Concentration - 8-12 hr
  • Elimination Half-life - 13 hr
  • Duration of Action - 24 hr

49

Sodium Glucose Cotransorter Inhibitors (SGLT2 Inhibitors)

The inhibitors are a new class of oral drugs for the treatment of type 2 diabetes mellitus. They inhibit glucose reabsorption in the proximal renal tubules. They work independently of insulin to prevent glucose reabsorption, which results glycosuria.

50

Which is the most appropriate timing regarding the nurse's administration of a rapid-acting insulin to a hospitalized patient?

  1. Give it 15 minutes before the patient begins a meal.
  2. Give it image hour before a meal.
  3. Give it 1 hour after a meal.
  4. The timing of the insulin injection does not matter with insulin lispro.
  • Give it 15 minutes before the patient begins a meal.

51

Which statement is appropriate for the nurse to include in patient teaching regarding type 2 diabetes?

  1. “Insulin injections are never used with type 2 diabetes.”
  2. “You don't need to measure your blood glucose levels because you are not taking insulin injections.”
  3. “A person with type 2 diabetes still has functioning beta cells in his or her pancreas.”
  4. “Patients with type 2 diabetes usually have better control over their diabetes than those with type 1 diabetes.”
  • “A person with type 2 diabetes still has functioning beta cells in his or her pancreas.”

52

The nurse monitoring a patient for a therapeutic response to oral antidiabetic drugs will look for

  1. fewer episodes of diabetic ketoacidosis (DKA).
  2. weight loss of 5 pounds.
  3. hemoglobin A1C levels of less than 7%.
  4. glucose levels of 150 mg/dL.

<ul> <li>hemoglobin A1C levels of less than 7%.</li> </ul> <br>

53

A patient with type 2 diabetes is scheduled for magnetic resonance imaging (MRI) with contrast dye. The nurse reviews the orders and notices that the patient is receiving metformin (Glucophage). Which action by the nurse is appropriate?

  1. Proceed with the MRI as scheduled.
  2. Notify the radiology department that the patient is receiving metformin.
  3. Expect to hold the metformin the day of the test and for 48 hours after the test is performed.
  4. Call the prescriber regarding holding the metformin for 2 days before the MRI is performed.
  • Expect to hold the metformin the day of the test and for 48 hours after the test is performed.

54

A patient with type 2 diabetes has a new prescription for repaglinide (Prandin). After 1 week, she calls the office to ask what to do, because she keeps missing meals. “I work right through lunch sometimes, and I'm not sure whether I need to take it. What do I need to do?” What is the nurse's best response?

  1. “You need to try not to skip meals, but if that happens, you will need to skip that dose of Prandin.”
  2. “We will probably need to change your prescription to insulin injections because you can't eat meals on a regular basis.”
  3. “Go ahead and take the pill when you first remember that you missed it.”
  4. “Take both pills with the next meal, and try to eat a little extra to make up for what you missed at lunchtime.”
  • “You need to try not to skip meals, but if that happens, you will need to skip that dose of Prandin.”

55

When checking a patient's fingerstick blood glucose level, the nurse obtains a reading of 42 mg/dL. The patient is awake but states he feels a bit “cloudy-headed.” After double-checking the patient's glucose level and getting the same reading, which action by the nurse is most appropriate?

  1. Administer two packets of table sugar.
  2. Administer oral glucose in the form of a semisolid gel.
  3. Administer 50% dextrose IV push.
  4. Administer the morning dose of lispro insulin.
  • Administer oral glucose in the form of a semisolid gel.

56

A patient is taking metformin for new-onset type 2 diabetes mellitus. When reviewing potential adverse effects, the nurse will include information about: (Select all that apply.)

  1. Abdominal bloating
  2. Nausea
  3. Diarrhea
  4. Headache
  5. Weight gain
  6. Metallic taste
  • Abdominal bloating
  • Nausea
  • Diarrhea
  • Metallic taste

57

A patient who has a new diagnosis of type 2 diabetes asks the nurse about a new insulin that can be inhaled. “Is there a reason I can't take that drug?” Which condition, if present in the patient, would be a concern?

  1. Atrial fibrillation
  2. Chronic lung disease
  3. Hypothyroidism
  4. Rheumatoid arthritis
  • Chronic lung disease

58

Which is a rapid-acting insulin with an onset of action of less than 15 minutes?

  1. Insulin glargine (Lantus)
  2. Insulin aspart (NovoLog)
  3. Insulin detemir (Levemir)
  4. Regular insulin (Humulin R)
  • Insulin aspart (NovoLog)

59

Which long-acting insulin mimics natural, basal insulin with no peak action and a duration of 24 hours?

  1. Insulin glargine (Lantus)
  2. Insulin glulisine (Apidra)
  3. Regular insulin (Humulin R)
  4. NPH insulin
  • Insulin glargine (Lantus)

60

Which insulin can be administered by continuous intravenous (IV) infusion?

  1. Insulin glargine (Lantus)
  2. Insulin aspart (Novolog)
  3. Insulin detemir (Levemir)
  4. Regular insulin (Humulin R)
  • Regular insulin (Humulin R)

61

Assuming the patient eats breakfast at 8:30 AM, lunch at noon, and dinner at 6:00 AM, he or she is at highest risk of hypoglycemia after an 8:00 AM dose of NPH insulin at what time?

  1. 10:00 AM
  2. 2:00 PM
  3. 5:00 PM
  4. 8:00 PM
  • 5:00 PM

62

The nurse is preparing a patient for a computed tomography scan using iodine contrast media. Which medication should the nurse question if prescribed one day before the scheduled procedure?

  1. Acarbose (Precose)
  2. Pioglitazone (Actos)
  3. Repaglinide (Prandin)
  4. Metformin (Glucophage)
  • Metformin (Glucophage)

63

Which oral hypoglycemic drug has a quick onset and short duration of action, enabling the patient to take the medication 30 minutes before eating and skip the dose if he or she does not eat?

  1. Acarbose (Precose)
  2. Metformin (Glucophage)
  3. Repaglinide (Prandin)
  4. Pioglitazone (Actos)
  • Repaglinide (Prandin)

64

Pramlintide (Symlin) is prescribed as supplemental drug therapy to the treatment plan for a patient with type 1 diabetes mellitus. What information should the nurse include when teaching the patient about the action of this medication?

  1. Pramlintide slows gastric emptying.
  2. Pramlintide increases glucagon excretion.
  3. Pramlintide stimulates glucose production.
  4. Pramlintide corrects insulin receptor sensitivity.
  • Pramlintide slows gastric emptying.

65

The patient is prescribed 30 units of regular insulin and 70 units of insulin isophane suspension (NPH insulin) subcutaneously every morning. The nurse should provide which instruction to the patient for insulin administration?

  1. “Inject the needle at a 30-degree angle.”
  2. “Rotate sites at least once or twice a week.”
  3. “Use a 23- to 25-gauge syringe with a 1-inch needle to increase insulin absorption.”
  4. “Draw up the regular insulin into the syringe first, followed by the cloudy NPH insulin.”
  • “Draw up the regular insulin into the syringe first, followed by the cloudy NPH insulin.

66

When teaching a patient about insulin glargine (Lantus), which statement by the nurse about this drug is correct?

  1. “You can mix this insulin with NPH insulin to enhance its effects on glucose metabolism.”
  2. “You cannot mix this insulin with regular insulin and thus will have to take two injections.”
  3. “It is often combined with regular insulin to decrease the number of insulin injections per day.”
  4. “The duration of action for this insulin is 8 to10 hours, so you will need to take it twice a day.”
  • “You cannot mix this insulin with regular insulin and thus will have to take two injections.”

67

The nurse is providing education to a patient for the prescription glipizide (Glucotrol). The nurse explains this medication is more effective when administered at which time?

  1. At bedtime
  2. In the morning
  3. 15 minutes postprandial
  4. 30 minutes before a meal
  • 30 minutes before a meal

68

The nurse will instruct the patient to treat hypoglycemia with which drug?

  1. Acarbose (Precose)
  2. Propranolol (Inderal)
  3. Glucagon (GlucaGen)
  4. Bumetanide (Bumex)
  • Glucagon (GlucaGen)

69

When caring for a pregnant patient with gestational diabetes, the nurse should question a prescription for which drug?

  1. Insulin glargine (Lantus)
  2. Glipizide (Glucotrol)
  3. Insulin glulisine (Apidra)
  4. NPH insulin
  • Glipizide (Glucotrol)

70

Which information should the nurse include in a teaching plan for patients taking oral hypoglycemic drugs? (Select all that apply.)

  1. Take your medication only as needed.
  2. Report symptoms of anorexia and fatigue.
  3. Explain dietary changes are not necessary.
  4. Advise to avoid smoking and alcohol consumption.
  5. Instruct that it is okay to skip breakfast 1 to 2 times per week.
  • Report symptoms of anorexia and fatigue.
  • Advise to avoid smoking and alcohol consumption.

71

Which actions describe the beneficial effects produced by sulfonylurea oral hypoglycemics? (Select all that apply.)

  1. Stimulate insulin secretion from beta cells
  2. Increase hepatic glucose production
  3. Enhance action of insulin in various tissues
  4. Inhibit breakdown of insulin by liver
  • Stimulate insulin secretion from beta cells
  • Enhance action of insulin in various tissues
  • Inhibit breakdown of insulin by liver